 Home > Medical News > Medical Research Articles > WuXi Biologics and ImmuneOncia of South Korea signed a memorandum of understanding for the development and production of anti-PD-L1/CD47 bispecific antibodies

WuXi Biologics and ImmuneOncia of South Korea signed a memorandum of understanding for the development and production of anti-PD-L1/CD47 bispecific antibodies

 Last Update: 2022-01-09
 Source: Internet
 Author: User

Tags

new antidepressants

company

new blue pigment

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

According to the memorandum of cooperation, ImmuneOncia will promote the development of this innovative bispecific antibody through WuXi Biologics' end-to-end services in cell line development, cell culture process development, biologics production, and bioassay method development .

Mr.

Dr.

About ImmuneOncia

ImmuneOncia is a biopharmaceutical company focusing on the field of tumor immunity

About WuXi Biologics

WuXi Biologics (stock code: 2269.

As of June 30, 2021, 408 comprehensive projects have been developed on WuXi Biologics platform, including 212 in preclinical research phase, 160 in early clinical (phase I/II) phase, and 32 in late clinical phase ( Phase III) and 4 are in the commercial production stage

WuXi Biologics regards environment, society and governance (ESG) as an important part of business development and corporate spirit, and is committed to becoming a global ESG leader in the field of biopharmaceuticals

For more information, please contact:

Media Relations

Investor Relations

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Neopentyl Glycol CAS NO.126-30-7 99% High Quality Factory Supply

CAS No.: 126-30-7

Industrial Grade

$1.7-2/KG FOB

Factory Supply Tirzepatide 10 mg 15mg Weight Loss Peptide 10mg 99.9% CAS: 2023788-19-2

CAS No.: 2023788-19-2

Pharmacy Grade

$4-5/UNIT FOB

good quality 2cb wholesale

CAS No.: 58743-75-2

$2-2.2/MT EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.